michigan semaglutide digestive blockage attorney FDA probes side effects of weight-loss drugs Weight Loss Drugs Lawsuit |

According to MediaRadar, Novo spent $316 million advertising Wegovy and $169 million advertising Ozempic in the first nine months of 2025, up more than 50% from the previous year

August 15 Product : AstraZenecas Imfinzi Indication : Perioperative non-small cell lung cancer AstraZeneca won a new indication for Imfinzi on Thursday when the FDA green lit the drug, along with platinum-containing chemotherapy, for the perioperative treatment of non-small cell lung cancer (NSCLC)

doi: 10.1038/387381a0

The first GLP-1 drug, Exenatide (brand name Byetta), was approved by the Food and Drug Administration in 2005 to treat type 2 diabetes

Follow-up visits are another charge too